Tubular function in multiple myeloma.

Area of Science:

• Nephrology
• Oncology
• Biochemistry

Background:

• Light chain proteinuria is associated with renal damage in multiple myeloma.
• The specific nephrotoxic potential of different light chains requires further elucidation.
• Early detection of tubular injury and dysfunction is crucial for managing myeloma-related kidney disease.

Purpose of the Study:

• To confirm the association between light chain proteinuria and renal damage in myeloma patients.
• To investigate the role of the amount and type of excreted light chains in nephrotoxicity.
• To identify sensitive markers for tubular injury and dysfunction in myeloma-associated kidney disease.

Main Methods:

• Analysis of light chain excretion and renal function markers in 42 myeloma patients.
• Measurement of N-acetyl-beta-D-glucosaminidase (NAG) as an index of proximal tubular injury.
• Assessment of low molecular weight proteinuria (Retinol Binding Protein, Lysozyme) for tubular dysfunction.
• Evaluation of distal tubular function (acid load, concentrating ability) and association with specific conditions.

Main Results:

• Confirmed association between light chain proteinuria and renal damage.
• Identified specific light chains as potentially nephrotoxic, beyond mere quantity.
• N-acetyl-beta-D-glucosaminidase excretion was a sensitive marker of tubular injury.
• Low molecular weight proteinuria indicated tubular dysfunction in kidneys with impaired Glomerular Filtration Rate (GFR).
• Isolated distal tubular defects were rare, usually part of global impairment or specific conditions like hyperviscosity or crystal deposition.
• Hypercalcemia specifically impaired concentrating ability, independent of acidification defects.

Conclusions:

• The type of light chain, not just the amount, is critical for nephrotoxicity in myeloma.
• Urinary N-acetyl-beta-D-glucosaminidase and low molecular weight proteins are valuable biomarkers for myeloma-related kidney injury.
• Distal tubular dysfunction is uncommon in isolation and often linked to specific myeloma complications.
• Hypercalcemia has a distinct impact on renal concentrating ability.